This is a StreetInsider.com Premium Only Page

ChemoCentryx (CCXI) –

Oct 31, 2022 06:07 AM Form 15-12G ChemoCentryx, Inc.

Oct 24, 2022 07:14 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: Jain Rita

Oct 24, 2022 07:10 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: Herron Jennifer Lyn

Oct 24, 2022 07:10 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: Edwards Thomas A.

Oct 24, 2022 07:08 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: Parker Geoffrey M.

Oct 24, 2022 07:07 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: KANAYA SUSAN M

Oct 24, 2022 07:03 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: Tyree James L

Oct 24, 2022 07:02 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: Schall Thomas J.

Oct 24, 2022 07:02 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: FECZKO JOSEPH M

Oct 24, 2022 06:59 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: Cappel Markus J.

Oct 24, 2022 06:58 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: Butt Tausif

Oct 24, 2022 06:58 PM Form 4 ChemoCentryx, Inc. For: Oct 20 Filed by: Wheadon David E.

Oct 20, 2022 09:28 AM Form S-8 POS ChemoCentryx, Inc.

Oct 20, 2022 09:27 AM Form S-8 POS ChemoCentryx, Inc.

Oct 20, 2022 09:27 AM Form POSASR ChemoCentryx, Inc.

Oct 20, 2022 09:20 AM Form 8-K ChemoCentryx, Inc. For: Oct 20

Oct 20, 2022 09:06 AM Amgen (AMGN) Completes Acquisition of ChemoCentryx (CCXI)

Oct 20, 2022 09:05 AM AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX

Oct 20, 2022 08:41 AM Form 25-NSE ChemoCentryx, Inc. Filed by: Nasdaq Stock Market LLC

Oct 18, 2022 04:17 PM Form 8-K ChemoCentryx, Inc. For: Oct 18

Oct 17, 2022 08:30 AM ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings

Oct 17, 2022 08:30 AM ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings

Oct 7, 2022 04:36 PM Form DEFA14A ChemoCentryx, Inc.

Oct 5, 2022 08:30 AM ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 5, 2022 08:30 AM ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Sep 20, 2022 09:02 AM ChemoCentryx (CCXI) Said HSR Waiting Period Related to Amgen (AMGN) Merger Expired

Sep 20, 2022 06:03 AM Form 8-K ChemoCentryx, Inc. For: Sep 19

Sep 20, 2022 06:03 AM Form DEFA14A ChemoCentryx, Inc.

Sep 14, 2022 05:32 PM Form DEFM14A ChemoCentryx, Inc.

Sep 12, 2022 11:14 AM Form SC 13G/A ChemoCentryx, Inc. Filed by: FMR LLC

Aug 31, 2022 05:08 PM Form PREM14A ChemoCentryx, Inc. For: Aug 31

Aug 31, 2022 06:02 AM Form DEFA14A ChemoCentryx, Inc.

Aug 24, 2022 08:30 AM ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences

Aug 24, 2022 08:30 AM ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences

Aug 23, 2022 06:02 AM Form DEFA14A ChemoCentryx, Inc.

Aug 18, 2022 04:49 PM Form 4 ChemoCentryx, Inc. For: Aug 16 Filed by: KANAYA SUSAN M

Aug 10, 2022 03:28 AM Stifel Downgrades ChemoCentryx (CCXI) to Hold

Aug 9, 2022 04:13 PM Form DEFA14A ChemoCentryx, Inc.

Aug 9, 2022 08:30 AM ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call

Aug 9, 2022 08:30 AM ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call

Aug 8, 2022 07:41 PM Form 4 ChemoCentryx, Inc. For: Aug 04 Filed by: Schall Thomas J.

Aug 8, 2022 07:33 PM Form 4 ChemoCentryx, Inc. For: Aug 04 Filed by: KANAYA SUSAN M

Aug 8, 2022 07:27 PM Form 4 ChemoCentryx, Inc. For: Aug 04 Filed by: Tyree James L

Aug 8, 2022 07:22 PM Form 4 ChemoCentryx, Inc. For: Aug 04 Filed by: Cappel Markus J.

Aug 8, 2022 05:02 PM Form 10-Q ChemoCentryx, Inc. For: Jun 30

Aug 8, 2022 08:01 AM Form DEFA14A ChemoCentryx, Inc.

Aug 7, 2022 08:05 PM CHEMOCENTRYX, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of CCXI and Encourages Investors to Contact the Firm

Aug 5, 2022 06:42 AM SVB Leerink Downgrades ChemoCentryx (CCXI) to Market Perform

Aug 5, 2022 06:18 AM H.C. Wainwright Downgrades ChemoCentryx (CCXI) to Neutral

Aug 5, 2022 04:09 AM Canaccord Genuity Downgrades ChemoCentryx (CCXI) to Hold